Name: Gross Profit Margin

Definition: Gross profit margin shows how much profit the company keeps from each dollar of sales after covering the direct cost of making its products or delivering services. High margins suggest strong pricing power or efficient production. Shrinking margins might mean rising costs or tougher competition eating into profits.

Interpretation:
• In '2021', HYPR's gross profit margin was -78.0%, showing profitability after production and operational costs. Industry average for Biotechnology: Electromedical & Electrotherapeutic Apparatus in '2021' stood at 52.9%.
• In '2022', HYPR's gross profit margin was 13.3%, showing profitability after production and operational costs. The increase since '2021' reflects strengthening financial performance. Industry average for Biotechnology: Electromedical & Electrotherapeutic Apparatus in '2022' stood at 58.8%. Industry average increased by 6.0% compared to previous year.
• In '2023', HYPR's gross profit margin was 43.1%, showing profitability after production and operational costs. The increase since '2022' reflects strengthening financial performance. Industry average for Biotechnology: Electromedical & Electrotherapeutic Apparatus in '2023' stood at 59.2%. Industry average increased by 0.4% compared to previous year.
• In '2024', HYPR's gross profit margin was 45.7%, showing profitability after production and operational costs. The increase since '2023' reflects strengthening financial performance. Industry average for Biotechnology: Electromedical & Electrotherapeutic Apparatus in '2024' stood at 49.2%. Industry average declined by 10.1% from previous year.
Overall, HYPR's gross profit margin has been volatile but showed an upward trend over the past 4 years.

Formula: Gross Profit Margin = (Revenue - COGS) / Revenue

Good Range: Often 20%-60% depending on industry.